On the stock market since 1991, it operates in the world of health and science. It has 6 employees. Now — the numbers.
This is an established company with proven profits.
An average decline of 3% a year over the last 4 years — the most striking risk in this picture.
If every debt were paid off today, $936K would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Revenue Growth: Sales are growing slowly.
An investor who bought at the very peak is down 79% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
There is $1.2M in the vault; even if every debt were paid off, $936K would remain.
The stock sits at $0.08. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
Over the last 3 years, sales grew only 1% a year on average. At this size, speeding back up is not easy.
On our five-subject report card, IVRO sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: IVRO is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.